Bamlanivimab Biosimilar - Research Grade

Human

SARS-CoV-2

5mg/ml

Human IgG1 Kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects SARS-CoV-2

Blue ice

The SARS-CoV-2 spike glycoprotein mediates host-cell entry and is the dominant antigen across coronavirus and vaccine research. This recombinant anti-SARS-CoV-2 monoclonal is an unconjugated, non-therapeutic analog of bamlanivimab, supplied for research use only (RUO). It is produced to rigorous in vivo standards, carries low endotoxin, and is delivered in scalable milligram (mg) to gram (g) quantities to meet bulk and high-throughput demand. The reagent suits functional assays, neutralisation and receptor-binding-domain studies, reproducible reference controls, and in vivo models of coronavirus infection, providing the consistency required for large neutralisation and binding campaigns.

ICH3002

https://www.imgt.org/mAb-DB/